Erratum: Inhibition of ADP-induced platelet aggregation by apoE is not mediated by membrane cholesterol depletion (Thrombosis Research 80 (6), pp. 499-508)

Thrombosis Research

Volumn 81, Issue 5, 1996, Pages 597-606

  Riddell, D R ^a   Owen, J S ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR; PRIORITY JOURNAL; ANIMAL; ARTICLE; CELL MEMBRANE; DRUG EFFECT; HUMAN; METABOLISM; RABBIT; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CHOLESTEROL; DIMYRISTOYLPHOSPHATIDYLCHOLINE; LIPOSOME;

ADENOSINE DIPHOSPHATE; ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; BLOOD PLATELETS; CELL MEMBRANE; CHOLESTEROL; DIMYRISTOYLPHOSPHATIDYLCHOLINE; HUMANS; LIPOSOMES; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RABBITS;

EID: 0030090385     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)87301-4     Document Type: Erratum

References (42)

1. N.E. Miller Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis Amer. Heart J. 113 1987 589 597
2. E.R. Skinner High-density lipoprotein subclasses Curr. Opin. Lipidol. 5 1994 241 247
3. S. Eisenberg High density lipoprotein metabolism J. Lipid Res. 25 1984 1017 1058
4. C.J. Fielding P.E. Fielding Molecular physiology of reverse cholesterol transport J. Lipid Res. 36 1995 211 228
5. A. Von Eckardstein H. Huang G. Assmann Physiological role and clinical relevance of high-density lipoprotein subclasses Curr. Opin. Lipidol. 5 1994 404 416
6. B.H. Chung J.P. Segrest K. Smith F.M. Griffin C.G. Brouillette Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein. A possible mechanism of atherogenesis? J. Clin. Invest. 83 1989 1363 1374
7. C. Paszty N. Maeda J. Verstuyet E.M. Rubin Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice J. Clin. Invest. 94 1994 899 903
8. S. Parthasarathy J. Barnett L.G. Fong High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein Biochim. Biophys. Acta 1044 1990 275 283
9. 2+-catalyzed oxidation of human low density lipoprotein FEBS Lett. 257 1989 435 438
10. U. Saxena E. Ferguson C.L. Bisgaier Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix J. Biol. Chem. 268 1993 14812 14819
11. M. Navab S.S. Imes S.Y. Hama G.P. Hough L.A. Ross R.W. Bork A.J. Valente D.C. Drinkwater H. Laks Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein J. Clin. Invest. 88 1991 2039 2046
12. W.A. Van Sickle H.G. Wilcox K.U. Malik A. Nasjletti High density lipoprotein-induced cardiac prostacyclin synthesis in vitro: relationship to cardiac arachidonate mobilization J. Lipid Res. 27 1986 517 522
13. Y. Yui T. Aoyama H. Morishita M. Takahashi Y. Takatsu C. Kawai Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I J. Clin. Invest. 82 1988 803 807
14. K. Desai K.R. Bruckdorfer R.A. Hutton J.S. Owen Binding of apoE-rich high density lipoprotein particles by saturable sites on human blood platelets inhibits agonist-induced platelet aggregation J. Lipid Res. 30 1993 831 840
15. H.M. Wilson J.C. Patel D. Russell E.R. Skinner Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease Clin. Chim. Acta 220 1993 175 187
16. G. Bittolo Bon G. Cazzolato M. Saccardi G.M. Kostner P. Avogaro Total plasma apo E and high density lipoprotein apo E in survivors of myocardial infarction Atherosclerosis 53 1984 69 75
17. K. Desai C. Bagget M.F. Bellamy P. Mistry A.K. Burroughs J.S. Owen Inhibition of platelet aggregation by abnormal high density lipoprotein particles in plasma from patients with hepatic cirrhosis Lancet i 1989 693 695
18. M. Higashihara M. Kinoshita T. Teramoto S. Kume K. Kurokawa The role of apoE in inhibitory effects of apoE-rich HDL on platelet function FEBS Lett. 282 1991 82 86
19. S.J. Shattil R. Anaya-Galindo J. Bennett R.W. Colman R.A. Cooper Platelet hypersensitivity induced by cholesterol incorporation J. Clin. Invest. 55 1975 636 643
20. S.C. Rall K.H. Weisgraber R.W. Mahley Isolation and characterization of apolipoprotein E Methods Enzymol. 128 1986 273 287
21. J.C. Osborne Delipidation of plasma lipoproteins Methods Enzymol. 128 1986 213 222
22. T.L. Innerarity R.E. Pitas R.W. Mahley Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts J. Biol. Chem. 254 1979 4186 4190
23. M.P.T. Gillett J.S. Owen Cholesterol esterifying enzymes-lecithin:cholesterol acyltransferase (LCAT) and acylcoenzyme A:cholesterol acyltransferase (ACAT) C.A. Converse E.R. Skinner Lipoprotein Analysis. A Practical Approach 1992 Oxford University Press Oxford 189 190
24. R.W. Mahley T.L. Innerarity S.C. Rall K.H. Weisgraber Plasma lipoproteins: apolipoprotein structure and function J. Lipid Res. 25 1984 1277 1294
25. S.J. Murdoch W.C. Breckenridge Development of a density gradient ultracentrifugation technique for the resolution of plasma lipoproteins which avoids apo E dissociation Analyt. Biochem. 222 1994 427 434
26. H. Mezdour S. Nomura T. Yamamura A. Yamamoto Concentration and distribution of apolipoproteins A-I and E in normolipidemic, WHHL and diet-induced hyperlipidemic rabbit sera Biochim. Biophys. Acta 1127 1992 116 123
27. K.H. Weisgraber Apolipoprotein E: structure-function relationships Adv. Protein Chem. 45 1994 249 302
28. B.R. Lee J.M. Miller C.Y. Yang L. Ramdas M.L. Yang J.D. Morrisett M.P. Mims Amino acid sequence of rabbit apolipoprotein E J. Lipid Res. 32 1991 165 171
29. S. Lund-Katz K.H. Weisgraber R.W. Mahley M.C. Phillips Conformation of apolipoprotein E in lipoproteins J. Biol. Chem. 268 1993 23008 23015
30. M.J. Stuart J.M. Gerrard J.G. White Effect of cholesterol on production of thromboxane B2 by platelets in vitro N. Engl. J. Med. 302 1980 6 10
31. P. Worner H. Patscheke Hyperreactivity by an enhanement of the arachidonate pathway of platelets treated with cholesterol-rich phospholipid-dispersions Thromb. Res. 18 1980 439 451
32. J.S. Owen H. Goodall P. Mistry D.S. Harry R.C. Day N. McIntyre Abnormal high density lipoproteins from patients with liver disease regulate cholesterol metabolism in cultured human skin fibroblasts J. Lipid Res. 25 1984 919 931
33. J.S. Owen S. Rafique E. Osman A.K. Burroughs Ability of S -adenosyl-L-methionine to ameliorate lipoprotein-induced membrane lipid abnormalities and cellular dysfunctions in humn liver disease Drug Invest. 4 Suppl. 4 1992 22 40
34. G.H. Rothblat L.Y. Arbogast E.K. Ray Stimulation of esterified cholesterol accumulation in tissue culture cells exposed to high density lipoproteins enriched in free cholesterol J. Lipid Res. 19 1978 350 358
35. A. Von Eckardstein G. Castro I. Wybranska N. Theret P. Duchateau N. Duverger J.C. Fruchart G. Alhaud G. Assmann Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165--> Arg) J. Biol. Chem. 268 1993 2616 2622
36. E.A. Brinton J.F. Oram C.h. Chen J.J. Albers E.L. Bierman Binding of high density lipoprotein to cultured fibroblasts after chemical alteration of apoprotein amino acid residues J. Biol. Chem. 261 1986 495 503
37. A.I. Maneva B.M. Taleva V.V. Manev L.M. Sirakov Lactoferrin binding to human platelets Int. J. Biochem. 25 1993 707 712
38. M. Huettinger H. Retzek M. Hermann H. Goldenberg Lactoferrin specifically inhibits endocytosis of chylomicron remnants but not alpha-macroglobulin J. Biol. Chem. 267 1992 18551 18557
39. H. Jingami T. Yamamoto The VLDL receptor: wayward brother of the LDL receptor Curr. Opin. Lipidol. 6 1995 104 108
40. J. Pedreno C. De Castellarnau C. Cullare J. Sanchez J. Gomez-Gerique F. Gonzalez-Sastre LDL binding sites on platelets differ from the “classical” receptor of nucleated cells Arterioscler. Thromb. 12 1992 1353 1362
41. M. Higashihara M. Kinoshita S. Kume T. Teramoto K. Kurokawa Inhibition of platelet function by high-density lipoprotein from a patient with apolipoprotein E deficiency Biochem. Biophys. Res. Commun. 181 1991 1331 1336
42. E. Malle W. Sattler Platelets and the lipoproteins: native, modified and platelet modified lipoproteins Platelets 5 1994 70 83